Tag: emergency use authorization

On Sunday, August 23, the US Federal Food and Drug Administration (FDA) announced an Emergency Use Authorization (EUA) for convalescent plasma as a treatment for hospitalized COVID-19 patients citing “known and potential benefits of the product outweigh the known and potential risks of the product.” The EUA would effectively enable physicians to treat COVID-19 patients… Continue reading COVID-19 Update: Convalescent Plasma